Business
Currency:CNY
2024/FY
Stock NameRevenueRatio
神经介入业务355.55M57.77%
经导管瓣膜治疗业务259.94M42.23%
Product
Currency:CNY
2024/FY
Stock NameRevenueRatio
神经介入业务355.55M57.77%
经导管瓣膜治疗业务259.94M42.23%
Region
Currency:CNY
2024/FY
Stock NameRevenueRatio
China615.48M100.00%